In thyroid carcinoma, miR-34b/c act as a potent modulator of proteins involved in angiogenesis (VEGF-A), apoptosis, and cell cycle regulation (Bcl-2 and Notch1)12. This evidence concerns the gene BCL2 and thyroid gland carcinoma.